AXSOME THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
AXSOME THERAPEUTICS, INC. (AXSM) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value of $951.61 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue · last filed 2026-08-10
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $951.61K.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $648.08K.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $745.28K.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $454.78K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value |
|---|---|
| 2026-06-30 | $951.61K 10-Q · filed 2026-08-10 |
| 2026-03-31 | $648.08K 10-Q · filed 2026-05-04 |
| 2025-12-31 | $745.28K 10-K · filed 2026-02-23 |
| 2025-09-30 | $454.78K 10-Q · filed 2025-11-03 |
| 2025-06-30 | $371.06K 10-Q · filed 2025-08-04 |
| 2025-03-31 | $435.56K 10-Q · filed 2025-05-05 |
| 2024-12-31 | $263.73K 10-K · filed 2025-02-18 |
| 2024-09-30 | $282.51K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $245.89K 10-Q · filed 2024-08-05 |
| 2024-03-31 | $238.93M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $232.38K 10-K · filed 2024-02-23 |
| 2023-09-30 | $183.51K 10-Q · filed 2023-11-06 |
| 2023-06-30 | $188.57K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $58.47K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $193.77M 10-K · filed 2023-02-28 |
| 2022-09-30 | $88.49M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $76.80M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $82.43M 10-Q · filed 2022-05-02 |
| 2021-12-31 | $71.15M 10-K · filed 2022-03-01 |
| 2021-09-30 | $149.26M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $145.92M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $178.26M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $175.58M 10-K · filed 2021-03-01 |
| 2020-09-30 | $142.29M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $159.41M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $100.57M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $178.99M 10-K · filed 2020-03-12 |
| 2019-09-30 | $22.43M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $31.67M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $12.11M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $191.12K 10-K · filed 2019-03-15 |
| 2018-09-30 | $937.44K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $796.43K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $456.61K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $2.04M 10-K · filed 2018-03-07 |
| 2017-09-30 | $2.01M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.99M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $1.10M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $2.73M 10-K · filed 2017-03-07 |
| 2016-09-30 | $3.44M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $3.09M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $3.66M 10-Q/A · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |